Guest guest Posted December 31, 2010 Report Share Posted December 31, 2010 Developing a web-based registry among community oncologists may be useful for collecting significant information about febrile events in patients with hematologic malignancies. Italian researchers have suggested that both morbidity and mortality could be lowered in this patient population through a computerized registry that collected data in a prospective manner. “We have developed what may be the first web-based registry to collect febrile events in hematologic malignancy patients so you can register a real-life picture of what is occurring in these patients,” said study investigator Morena Caira, MD, a research scientist at the Catholic University in Rome. Dr. Caira said developing such a system has allowed oncologists in Italy to create a complete system for the epidemiological study of infectious complications in this cancer patient population. It is a simple system that could be adopted in the U.S. on a community- wide, state-wide, or country-wide basis, she said. Source: Cancernetwork.com, December 30, 2010 _________________________________ December 10, 2010 December 7, 2010 Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia The median reductions in Bcr-Abl transcripts at one year were greater with dasatinib (Sprycel) than with imatinib (Gleevec), according to the results of an intergroup phase II trial. A better molecular response should eventually correlate with better outcomes, making dasatinib a serious contender... More » Source: Cancernetwork.com ___________________________ Mayo Clinic review of symptoms of CML and home remedies Clinical trials Clinical trials study the latest treatment for diseases or new ways of using existing treatments. Enrolling in a clinical trial for chronic myelogenous leukemia may give you the chance to try the latest treatment, but it can't guarantee a cure. Talk to your doctor about what clinical trials are available to you. Together you can discuss the benefits and risks of a clinical trial. Subscribe to our Living with cancer newsletter to stay up to date on cancer topics. For many people, chronic myelogenous leukemia is a chronic disease they will live with for years. Many will continue treatment with imatinib indefinitely. Some days, you may feel sick even if you don't look sick. And some days, you may just be sick of having cancer. Self-care measures to help you adjust and cope with a chronic illness. _________________________ December 12, 2010 Supportive care kit guides dasatinib Rx Bristol-Myers Squibb and Otsuka Pharmaceutical have launched My Sprycel Support, a resource to assist adult patients with chronic myeloid leukemia who are taking dasatinib (Sprycel). The program is designed to help patients learn more about dasatinib and how to be involved in treatment decisions with a healthcare provider. The kit contains information on dasatinib study data; dosing and potential side effects; and a journal to help track activities throughout the treatment process. The kit also contains a co-pay assistance brochure. If patients qualify for assistance, they could receive up to $100 per month toward their co-pay for a period of 12 months, with a maximum benefit of $1,200, according to Bristol- Myers Squibb. Enrolling in the program also grants patients 24-hour access to registered nurses who are trained as dasatinib counselors. Visit www.sprycel.com to learn more about the kit and affiliated program. Source: Cancernetwork.com __________________________ The ranks of the uninsured or underinsured have been on the rise, placing a burden on cancer patients and the programs that dispense treatment. A national poll conducted by the American Cancer Society Cancer Action Network found that, over the past two years, nearly one-half of cancer patients and survivors under age 65 said they are having difficulty affording healthcare costs, including paying for copays and prescription drugs (ACS CAN poll results, June 23, 2010). As a result, one in three patients under age 65 diagnosed with cancer delayed needed cancer-related tests, treatments, checkups, and filling of prescription drugs over the past year. Source: Cancernetwork.com, December 30, 2010 __________________________ Carpe Diem, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.